
Post hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.
A 6-year-old with a significant past medical history of asthma is rushed to the emergency department at midnight after experiencing a cyanotic spell.





